Key facts
- It has raised $350K; the latest was PE Growth/Expansion in Sep 2025.
- Notable investors include Capital Factory, M2O.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for TrueMed LIS
- ·The full record, as it builds
Funding rounds
No funding rounds for TrueMed LIS are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About TrueMed LIS
Developer of a cloud-based software designed to automate and optimize the medical diagnostic laboratory. The company's platform offers a comprehensive laboratory information management system and customer relationship management for infectious disease, COVID-19, cancer genomics, PGx, toxicology and hematology in one platform, offering medical diagnostic laboratories a portal for patients, physicians, sales and marketers, and laboratories.
- Sector
- Healthcare
- HQ
- Dallas, TX, United States
- Founded
- 2015
- Employees
- 12
- Website
- truemedlis.com/
- Ownership
- Privately Held (backing)
TrueMed LIS doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in TrueMed LIS shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on TrueMed LIS in its N-PORT filings yet. We sweep new filings monthly.